|
|
Biomarkers for Detection and Prediction of Chemotherapy-Related Cognitive Impairment |
| 3P30CA014520-48S5 |
|
NCI |
2022 |
|
|
Human Endogenous retroviruses as potential early markers for Alzheimers disease |
| 3R01CA226570-04S1 |
|
NCI |
2022 |
|
|
Integrative metabolomic characterization of ADHD and asthma comorbidity |
| 5K01HL153941-03 |
|
NHLBI |
2022 |
|
|
Association of Tau and Neuronal Hypometabolism with Positron Emission Tomography in Alzheimers Disease |
| 1F30AG074524-01A1 |
|
NIA |
2022 |
|
|
Effects of metabolic phenotype on functional connectivity in aging and Alzheimer’s Disease |
| 1F30AG076278-01 |
|
NIA |
2022 |
|
|
Fluency from Flesh to Filament: Collation, Representation, and Analysis of Multi-Scale Neuroimaging data to Characterize and Diagnose Alzheimers Disease |
| 1F30AG077736-01 |
|
NIA |
2022 |
|
|
Multimodal, multiclass prediction of disease status in Alzheimer’s |
| 1F30AG079610-01 |
|
NIA |
2022 |
|
|
AMPK localization, expression, and activity in Alzheimers Disease |
| 1F30AG079633-01 |
|
NIA |
2022 |
|
|
Explaining racial and ethnic Alzheimer’s disease disparities with joint estimation of life course social inequities and measurement bias in verbal memory assessment |
| 1F31AG076284-01 |
|
NIA |
2022 |
|
|
Single-cell epigenomic roadmap of Alzheimers disease |
| 1F31AG076308-01 |
|
NIA |
2022 |
